Literature DB >> 29276303

Administration of Injectable Vitamin K Orally.

Janna Afanasjeva1.   

Abstract

Background: Vitamin K, or phytonadione, is available in both injectable and oral formulations. Oral vitamin K is available as 5-mg tablets, but the key drawbacks for using vitamin K tablets consist of availability of only 1 dose strength and recent tripling of the product's cost over a 2-year period. An interest exists for utilization of injectable vitamin K via oral route. Method: A literature search was performed on April 26, 2017, to identify any studies describing the use of injectable vitamin K for oral administration. The search involved PubMed and Embase and utilized various combinations of keywords vitamin K, phytonadione, IV, intravenous, injectable, and oral. The results were limited to studies that discussed oral administration of injectable vitamin K. The efficacy of the injectable preparation of vitamin K administered orally was explored in 6 studies and one cost-savings project.
Results: Based on the available literature, the administration of injectable vitamin K via oral route is effective and safe. Injectable vitamin K for oral administration can be prepared as an undiluted solution or as a compounded solution. These 2 formulations have different beyond-use dates depending on ingredients used.
Conclusion: Information on efficacy and stability of injectable vitamin K formulations prepared for oral administration provides an additional option for health care systems when vitamin K tablets are unavailable or cost-prohibitive to use.

Entities:  

Keywords:  compounding; injectable; oral administration; phytonadione; stability; vitamin K

Year:  2017        PMID: 29276303      PMCID: PMC5735741          DOI: 10.1177/0018578717729663

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  12 in total

1.  A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.

Authors:  H G Watson; T Baglin; S L Laidlaw; M Makris; F E Preston
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

2.  [Oral administration of intravenous preparation of Vitamin K for excessive anticoagulation due to warfarin].

Authors:  Yoleima Lozada; Marinela Falcone; Ricardo Granero
Journal:  Medicina (B Aires)       Date:  2012       Impact factor: 0.653

Review 3.  Guidelines on oral anticoagulation with warfarin - fourth edition.

Authors:  David Keeling; Trevor Baglin; Campbell Tait; Henry Watson; David Perry; Caroline Baglin; Steve Kitchen; Michael Makris
Journal:  Br J Haematol       Date:  2011-06-14       Impact factor: 6.998

Review 4.  Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.

Authors:  Peter Baker; Ana Gleghorn; Teresa Tripp; Kevin Paddon; Helen Eagleton; David Keeling
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

5.  Phytonadione oral liquid.

Authors:  Janice L Stumpf; Scott L Ciarkowski; Noah Leja; Emily K Jaynes
Journal:  Am J Health Syst Pharm       Date:  2016-06-15       Impact factor: 2.637

6.  Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

Authors:  M A Crowther; J Julian; D McCarty; J Douketis; M Kovacs; L Biagoni; T Schnurr; J McGinnis; M Gent; J Hirsh; J Ginsberg
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

7.  An update of consensus guidelines for warfarin reversal.

Authors:  Huyen A Tran; Sanjeev D Chunilal; Paul L Harper; Huy Tran; Erica M Wood; Alex S Gallus
Journal:  Med J Aust       Date:  2013-03-04       Impact factor: 7.738

Review 8.  Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review.

Authors:  Sarah E Wilson; Henry G Watson; Mark A Crowther
Journal:  CMAJ       Date:  2004-03-02       Impact factor: 8.262

9.  Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

Authors:  M A Crowther; D Donovan; L Harrison; J McGinnis; J Ginsberg
Journal:  Thromb Haemost       Date:  1998-06       Impact factor: 5.249

10.  Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.

Authors:  Mark A Crowther; James D Douketis; Terri Schnurr; Luigi Steidl; Valentina Mera; Carolina Ultori; Achille Venco; Walter Ageno
Journal:  Ann Intern Med       Date:  2002-08-20       Impact factor: 25.391

View more
  2 in total

1.  Oral administration of injectable vitamin K1 in brodifacoum intoxication.

Authors:  Yen-Jung Chu; Jing-Hua Lin; Dong-Zong Hung
Journal:  Biomedicine (Taipei)       Date:  2022-06-01

Review 2.  Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases.

Authors:  Dina C Simes; Carla S B Viegas; Nuna Araújo; Catarina Marreiros
Journal:  Nutrients       Date:  2020-01-03       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.